Americas · News · Toronto Star

Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2

Published by Toronto Star · Canada 8 h ago

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

Read the full article on Toronto Star Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestar.com)

Also worth reading

CBC News

Raymond J. de Souza: Netanyahu's post-October 7 strategy has made Israel safer, but not safe

CTV News

Pet dies in Red Deer house fire | CTV News Red Deer for Oct. 6, 2026

Le Devoir

Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2

Share

Also worth reading

French, Japanese scientists share Nobel Prize in Chemistry

Amazon Prime Big Deal Days 2026: Your ultimate guide to must-shop deals

Anti-Zionism and antisemitism should not be conflated

Raymond J. de Souza: Netanyahu's post-October 7 strategy has made Israel safer, but not safe

Pet dies in Red Deer house fire | CTV News Red Deer for Oct. 6, 2026

Le prix Nobel de chimie décerné au Français Henri Kagan et au Japonais Kenso Soai